Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jason Rhodes Insider Profile
4 Followers
Jason Rhodes, President, CFO and Treasurer at Epizyme, holds 847.32K shares in Dyne Therapeutics (Ticker: DYN), holds 8.28M shares in Generation Bio (Ticker: GBIO), holds 3.23M shares in Replimune Group (Ticker: REPL). Most recently, Jason Rhodes Sold ― shares of Dyne Therapeutics on Nov 18, 2024 for an estimated value of 25.88K.
Jason Rhodes Epizyme (EPZM)President, CFO and Treasurer
Epizyme (EPZM)
President, CFO and Treasurer
Ranked #12,230 out of 99,335 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+78.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jason Rhodes holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jason Rhodes
Jason Rhodes's Trading History
Epizyme
Sep 24, 2014
―
Informative Buy
22.44K
$202.86K
Replimune Group
Jan 28, 2021
Director
Uninformative Sell
256.45K
$35.68M
Generation Bio
Sep 29, 2021
Director
Uninformative Sell
2.06M
$10.93M
Dyne Therapeutics
Nov 18, 2024
Director
Informative Sell
25.88K
$25.19M
Disc Medicine
―
Director, Ten Percent Owner
―
―
List of latest transactions for each holding click on a transaction to see Jason Rhodes's performance on stock
You May Also Like
Jason Rhodes insider profile FAQ
What is the percentage of profitable transactions made by Jason Rhodes?
The percentage of profitable transactions made by Jason Rhodes is 33%.
What is the average return per transaction made by Jason Rhodes?
The average return per transaction made by Jason Rhodes is 78.70%.
What stocks does Jason Rhodes hold?
Jason Rhodes holds: EPZM, REPL, GBIO, DYN, IRON stocks.
What was Jason Rhodes’s latest transaction?
Jason Rhodes latest transaction was an Informative Sell of $25.88K.
What was Jason Rhodes's most profitable transaction?
Jason Rhodes’s most profitable transaction was an Informative Buy of REPL stock on November 20, 2019. The return on the trade was 276.70%.
What is Jason Rhodes's role in Epizyme?
Jason Rhodes's role in Epizyme is President, CFO and Treasurer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.